Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)

NCT03162653 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03162653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Unknown status
Start date
March 25, 2018
Completion date
January 31, 2026
Enrollment
760 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

encephalopathy, hypoxic-ischemic, infant, newborn, diseases